Download PDF
Thromb Haemost 2000; 84(03): 514
DOI: 10.1055/s-0037-1614060
Letters to the Editor
Schattauer GmbH

Influence of Fluvastatin on Levels of von Willebrand Factor in Cardiac Transplant Recipients

A. D. Blann
1   From the Haemostasis, Thrombosis and Vascular Biology Unit, City Hospital, University Dept. of Medicine, Birmingham, UK
› Author Affiliations
Further Information

Publication History

Received 10 April 2000

Accepted 17 April 2000

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Ambrosi P, Aillaud MF, Habib G, Kreitmann B, Matras D, Luccioni R, Bouvenot G, Juhan-Vague I. Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients. Thromb Haemost 2000; 83: 46-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Collins P, Wilkie M, Razak K, Abbott S, Harley S, Bax C, Zaidi M, Blake D, Cunningham J, Newland A. Cyclosporin and cremaphor modulate von Willebrand factor release from cultured endothelial cells. Transplantation 1993; 56: 1218-23.
    CrossrefPubMedSearch in Google Scholar
  • 3 Licciardello JTW, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296-300.
    CrossrefPubMedSearch in Google Scholar
  • 4 Richard S, Seigneur M, Blann A, Adams R, Renard M, Puntous M, Boiron JM, Amiral J, Reiffers J, Boisseau M. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 18: 955-9.
    PubMedSearch in Google Scholar